Creatinine Clearance Calculator / eGFR values
eGFR 51 mL/min/1.73 m²
Check what an eGFR of 51 means, or calculate your own eGFR and creatinine clearance.
Your result
Enter the values and press the button. The result appears here.
What an eGFR of 51 means
An eGFR of 51 mL/min/1.73 m² falls in KDIGO category G3a (mildly to moderately decreased, 45–59).
An eGFR below 60 that lasts more than three months meets the KDIGO definition of chronic kidney disease.
Creatinine that gives eGFR 51
| Age | Men (mg/dL) | Men (µmol/L) | Women (mg/dL) | Women (µmol/L) |
|---|---|---|---|---|
| 25 | 1.86 | 164 | 1.46 | 129 |
| 35 | 1.76 | 156 | 1.38 | 122 |
| 45 | 1.67 | 148 | 1.31 | 116 |
| 55 | 1.59 | 140 | 1.25 | 110 |
| 65 | 1.51 | 133 | 1.18 | 105 |
| 75 | 1.43 | 127 | 1.13 | 99 |
| 85 | 1.36 | 120 | 1.07 | 94 |
Solved from the CKD-EPI 2021 equation.
eGFR 51 in mL/min for your body size
| BSA (m²) | mL/min |
|---|---|
| 1.50 | 44 |
| 1.70 | 50 |
| 1.90 | 56 |
| 2.10 | 62 |
| 2.30 | 68 |
De-indexed eGFR is still not the same as Cockcroft-Gault creatinine clearance.
All stages
| GFR category | eGFR (mL/min/1.73 m²) | Description |
|---|---|---|
| G1 | 90 or higher | Normal or high |
| G2 | 60–89 | Mildly decreased |
| G3a | 45–59 | Mildly to moderately decreased |
| G3b | 30–44 | Moderately to severely decreased |
| G4 | 15–29 | Severely decreased |
| G5 | below 15 | Kidney failure |
Common questions
Is an eGFR of 51 normal?
It is in category G3a (mildly to moderately decreased). If it persists for three months it meets the definition of CKD.
What stage of CKD is eGFR 51?
GFR category G3a (45–59 mL/min/1.73 m²).
Related calculators
Sources
- Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C–based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737–1749.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117–S314.
- Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79(2):268–288.
For information only. These tools do not diagnose any condition and do not replace a doctor or your prescriber or pharmacist. Last reviewed November 2026.